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ABSTRACT
Objective: Poor diet can be detrimental to mental health. However, the overall evidence for the effects of dietary interventions on mood
and mental well-being has yet to be assessed. We conducted a systematic review and meta-analysis examining effects of dietary interven-
tions on symptoms of depression and anxiety.
Methods: Major electronic databases were searched through March 2018 for all randomized controlled trials of dietary interventions
reporting changes in symptoms of depression and/or anxiety in clinical and nonclinical populations. Random-effects meta-analyses were
conducted to determine effect sizes (Hedges' g with 95% confidence intervals [CI]) for dietary interventions compared with control con-
ditions. Potential sources of heterogeneity were explored using subgroups and meta-regression analyses.
Results: Sixteen eligible randomized controlled trials (published in English) with outcome data for 45,826 participants were included; the
majority of which examined samples with nonclinical depression (n = 15 studies). Nonetheless, dietary interventions significantly reduced
depressive symptoms (g = 0.275, 95% CI = 0.10 to 0.45, p = .002). Similar effects were observed among high-quality trials (g = 0.321,
95% CI = 0.12 to 0.53, p = .002) and when compared with both inactive (g = 0.308, 95% CI = 0.02 to 0.60, p = .038) and active controls
(g = 0.174, 95%CI = 0.01 to 0.34, p = .035). No effect of dietary interventions was observed for anxiety (k = 11, n = 2270, g = 0.100, 95%CI =
−0.04 to 0.24, p = .148). Studies with female samples observed significantly greater benefits from dietary interventions, for symptoms of
both depression and anxiety.
Conclusions: Dietary interventions hold promise as a novel intervention for reducing symptoms of depression across the population. Fu-
ture research is required to determine the specific components of dietary interventions that improve mental health, explore underlying
mechanisms, and establish effective schemes for delivering these interventions in clinical and public health settings.
Registration: PROSPERO Online Protocol: CRD42018091256.
Key words: affective disorders, mental illness, mood, nutrients, nutrition.
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INTRODUCTION
Depressive disorders affect more than 300million people aroundtheworld and are associatedwith unemployment, poor physical
health, impaired social functioning, and, in its most severe forms,
suicide (1). Thus, depressive disorders incur considerable burden
not only for individuals but also for society because of the high
economic cost from lost productivity and demand on healthcare
services (2). The same can be said for anxiety disorders, which,
along with depression, are also classified as “common mental
disorders” because of their prevalence across the globe, with
approximately one in five people experiencing one of these
conditions for any given year (3). Standard treatments for com-
mon mental disorders comprise psychopharmacological and
psychotherapeutic interventions. Although these have established
efficacy in depression, a substantial proportion of people do not
achieve remission using such strategies (4).
Furthermore, subclinical symptoms of depression and anxiety
are also highly prevalent across the general population, among
those without clinically diagnosed commonmental disorders. These
symptoms, although falling short of diagnostic thresholds, still im-
pede upon quality of life and socio-occupational functioning, incur-
ring even further personal and economic burden on a population
scale (5). Therefore, new primary and/or adjunctive methods to
address symptoms of depression and anxiety across the population
are urgently needed.
Emerging evidence suggests that diet may influence the onset
of mood disorders and specifically depression. For instance, many
studies described in recent systematic reviews have demonstrated
associations between measures of diet quality and the probability
of and risk for depression (6,7). Moreover, proinflammatory die-
tary patterns are also associated with a significantly higher inci-
dence of depressive symptoms, even among those without diagnosed
mental disorders (8–10). A previous systematic review examined
the benefits of various dietary interventions for depressive symp-
toms and anxiety, but using only narrative synthesis (11). Results
generally suggested positive effects of dietary interventions
on subclinical depression and anxiety, measured as secondary
outcomes (11). However, the previous review did not apply
meta-analytic techniques to quantify the findings and the results
did not include recent interventions in clinical populations,
Thus, it remains unclear if dietary interventions can improve
symptoms of depressive and anxiety (in either clinical or nonpsy-
chiatric samples) and the magnitude of any effects. Moreover, the
potential influence of moderators such as sex, professional deliv-
ery, or the quality of studies on treatment outcomes is uncertain.
Therefore, we aimed to determine the efficacy of dietary interven-
tions for symptoms of depression and anxiety by conducting a
meta-analysis of all randomized controlled trials (RCTs) examin-
ing this therapeutic strategy to date. We also used subgroup anal-
yses to examine effects of dietary interventions on depression/
anxiety in both clinical and nonclinical populations and to explore
which aspects of these are associated with any potential greater
efficacy. The findings of this meta-analysis will provide the first
overall estimate of the efficacy of dietary interventions for reducing
symptoms of depression and anxiety, along with informing self-
management strategies for people with these conditions, and sug-
gest directions for future research.
METHODS
This meta-analysis followed the PRISMA statement for transparent, com-
prehensive reporting of methodology and results (12). To eliminate re-
searcher bias, the search strategy, inclusion criteria, and data extraction,
overall and prespecified subgroup analyses used in this meta-analysis were
prospectively registered with PROSPERO (CRD42018091256).
Search Strategy
The primary search was performed using OVIDMedline on December 03,
2018, in line with the preregistered protocol, using the key word terms
“Diet” with “Mediterranean” or “Therapy” or “Educat*” or “Counsel*”
or “Intervention*” or “Treatment*” AND “Randomized Controlled Trial”
or “Random Allocation” or “Clinical Trial” or “Control Groups” AND
“Depression” or “Anxiety” or “Depressive Disorder.”We performed addi-
tional searches of Cochrane Central Register of Controlled Trials, Health
Technology Assessment Database, Allied and Complementary Medicine
(AMED), Embase, Health Management Information Consortium (HMIC),
and PsycINFO, using the same keywords, along with a further general
search of “Google Scholar” to capture any articles not captured by the main
search. The full search details are presented in Supplemental Digital Con-
tent 1, http://links.lww.com/PSYMED/A537.
Eligibility Criteria
Only English articles published in peer-reviewed journals were included.
We aimed to determine effects of dietary interventions on symptoms of de-
pression and anxiety in all clinical and nonclinical populations, including
depression (e.g., major depressive disorder [MDD]) or anxiety, comorbid
depression, and anxiety, and in samples with depressive/anxiety symptoms
that did not reach clinical thresholds. No restrictionswere placed on diagnosis
or any other clinical or demographic characteristics of eligible samples.
Eligible studies were RCTs comparing the effect of dietary interven-
tions to nondietary control conditions. All “whole-of-diet” dietary interven-
tions were eligible, delivered via any format, including individualized dietary
counseling, group dietary classes, and standardized dietary prescription. In
addition, all “types” of diet were eligible, including those primarily aiming
to decrease the intake of unhealthy foods, improve nutrient intake, and/or
those designed to restrict calorie intake to order induce weight loss. Because
we aimed to establish the effects of whole-of-diet interventions for depression
and anxiety, rather than examining only individual foods/nutrients, interven-
tions focusing only on a single food component (e.g., eating more fish) were
not included. Multicomponent life-style interventions were only eligible
where comparator conditions had adequately controlled for active nondietary
aspects of the intervention. For instance, multicomponent interventions such
as “exercise with diet” would only be eligible if compared with an “exercise
alone” control condition, so that the effects of the dietary component could be
accurately determined. Crossover trials were only included where between-
group differences from the first leg of the crossover trial were reported (so
that parallel groups comparisons could be performed from the data).
Studies using both “inactive control groups” and “active control groups”
were eligible for inclusion. Inactive control groups were classified as those in
which participants maintained their habitual diets and received no additional
active intervention during the trial period (or put onto a “waitlist” until pre-
and postmeasures had been collected from both groups). Conversely, “active
control groups”were categorized as any that compared diet with other active
interventions or used comparator conditions designed to control for general
“intervention effects” using either (a) benign interventions not aiming to treat
depression/anxiety, (b) psychosocial interventions, e.g., social support,
counseling, or exercise, or (c) other forms of activities, such as “time and
attention”–matched patient contact.
CI= confidence interval,MDD =major depressive disorder, RCT=
randomized control trial
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All studies matching the previous criteria and reporting changes in at
least one quantitative measure of depression or anxiety with sufficient detail
for meta-analysis were included. Two independent investigators judged ar-
ticle eligibility (JF and RC) with any disagreements resolved through dis-
cussion. Where study design matched eligibly criteria, but data were
insufficiently reported, study authors were contacted twice for 2 months
to request the necessary data.
Data Extraction
A systematic extraction form was used to extract the following data from
each eligible study:
(i) Sample information: sample size (n), sex (% females), mean age of participants
(years), population sampled health status (diagnostic information or relevant in-
clusion criteria),
(ii) Intervention: primary aim of dietary change (e.g., weight loss or increasing nu-
tritional intake), dietary program summary, individual delivering the interven-
tion (e.g., dietitian or researcher), any additional intervention components
(e.g., in-person or remotely delivered nondietary additions), control condition,
intervention length (weeks).
(iii) Effects on depressive or anxiety symptoms: changes in total depressive/anxiety
symptoms before and after dietary and control conditions, using any clinically
validated rating scale. For studies that usedmore than 1measure of depression,
a mean total change was calculated by pooling outcomes from each measure.
Study quality was determined through applying the quality criteria from
the Academy of Nutrition and Dietetics (formerly the American Dietetic
Association [ADA]) in the ADA quality assessment tool (13). This applies
set criteria for examining allocation bias, selection bias, blinding, data col-
lection, trial retention (along with methods of handling dropouts), and in-
terventional adherence. Each study was categorized as positive, negative,
or neutral using the standardized “quality consideration questions” de-
scribed in the ADA Evidence Analysis Manual (13). All studies were in-
cluded in the meta-analysis, regardless of ADA rating.
Statistical Analyses
Meta-analyses were conducted using Comprehensive Meta-Analysis 2.0
(14), using a random-effects model (15) to account for the expected hetero-
geneity between studies. The total difference in changes in symptoms of de-
pression and anxiety from dietary interventions versus control conditions
were pooled to compute the overall effect size of dietary interventions (as
Hedges g), with 95% confidence intervals (CI). For RCTs reporting compar-
isons of dietary interventions with more than one control group, we pooled
comparisons with each control group to generate an overall estimated effect
of dietary interventions, to make use of all available data. For the one study
reporting sex groups separately (16), a combined estimate across both sexes
was calculated as Hedges g effect size and used for primary analyses. After
computing main effects, a sensitivity analysis was applied to investigate ef-
fects of dietary interventions in RCTs that had a “positive” ADA rating.
The degree of statistical heterogeneity in the meta-analyses was quanti-
fied using Cochran's Q and I2 values. Risk of publication bias was exam-
ined by applying Eggers' regression to all previously mentioned analyses.
Furthermore, a Duval and Tweedie's “trim-and-fill” analysis was applied
to the random-effects models, to recalculate the pooled effect size after sta-
tistically accounting for any studies that may introduce publication bias
(e.g., small studies with large effect sizes). In addition, a funnel plot of
study effect sizes was generated from primary analyses, for a visual inspec-
tion of publication bias.
Prespecified subgroup analyses were conducted to examine how effects
of dietary interventions differed when (a) comparing diet with either
waitlist/inactive control conditions or active control conditions, (b) in “clin-
ical” (i.e., patients with diagnosed depressive/anxiety disorder) and “non-
clinical” (i.e., people without diagnoses of depression or anxiety), or (c)
comparing interventions that had combined “diet with exercise” to control
groups using exercise alone. In addition, we conducted a range of post hoc
analyses, to examine putative factors that may influence the effects of die-
tary interventions. Specifically, we examined how changes in depressive
symptoms were influenced the following factors: studies' sex distribution,
mean sample age, type of diet used, how the intervention was delivered, in-
tervention length (weeks), and study quality (measured with ADA scale).
RESULTS
Included Studies and Participant Details
The full search and screening process are shown in Supplemental
Digital Content 1, http://links.lww.com/PSYMED/A537. After the
removal of duplicate articles from the systematic search of elec-
tronic databases, 26 articles were identified as potentially eligible
after the title and abstract screening stage. Screening of the full-text
versions resulted in 10 of these being excluded, and 16 identified as
eligible for inclusion. The additional search of Google Scholar iden-
tified further two possible trials, although these were deemed ineli-
gible after full-text screening. Details on the ineligible articles and
reasons for exclusion are displayed in Supplement 1, Supplemen-
tal Digital Content 1, http://links.lww.com/PSYMED/A537.
Therefore, a total of 16 RCTs were included in the analyses;
reporting outcome data from 45,826 individuals (median average
age = 55 years, range = 21–85 years). The results from the ADA
Quality Assessments for each study are displayed in Supplemental
Digital Content 2, http://links.lww.com/PSYMED/A538. This showed
that only one study scored 12/12 for study quality (17), 10 others met
the criteria for positive on ADA scale by scoring 9 or higher (catego-
rized as “high quality”) (18–27), and five studies scored lower than 9
(categorized as low/neutral quality) (16,28–31). One reported out-
come data in a format not suited for meta-analysis, but the corre-
sponding authors provided the required data for inclusion (23).
Depressive symptoms were measured by all 16 studies,
whereas anxiety outcomes were measured by only 11 of the
16 eligible trials. Changes in symptoms were assessed using
the total scores from the following measures: “Centre for Epi-
demiological Studies Depression” (19,22,32); the “Beck De-
pression Inventory” (16,21,27,28,33); the “Hamilton Rating
Scale for Depression” (28,34); the “Montgomery-Åsberg Depression
Rating Scale” (17,35); the Geriatric Depression Scale (23,29,36), the
Taylor Manifest Anxiety Scale (16,37), and the subscale scores for
depression/anxiety from the following measures: the “Hospital
Anxiety Depression Scale” (17,20,26,38); the Short-Form Health
Survey (18,27,39); the Brief Symptom Inventory (24,25,28,40);
the Profile Of Mood States (41) (17Wardle, 2000 #10083, 30,
31), and the General Well-Being Schedule (31,42). However, only
one study examined the effects of a dietary intervention in a sample
with primary diagnosis of clinical depression (17), with all the remain-
ing studies examining effects on comorbid, subclinical, or secondary
symptoms of depression/anxiety (see Table 1 for details). Across the
different types of diets used by the studies, nine interventions were
primarily aimed at improving nutrient intake (n = 9), four aimed
to decrease fat intake (n = 4), and four were designed to reduce
bodyweight (n = 4). The specifics of dietary interventions differed
substantially across studies, and summaries for each are displayed
in Table 1. Interventions ranged from 10 days to 3 years in length.
Overall Effects of Dietary Interventions on Depression
Figure 1 displays the pooled effect size from dietary interventions
on depressive symptoms, along with individual effects from each
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study. Table 2 displays the full results of all meta-analyses. A ran-
dom-effects meta-analysis of 16 RCTs, reporting outcome data
from 45,826 individuals, revealed that dietary interventions signif-
icantly reduced depressive symptoms in comparison to control
conditions, with a small pooled effect (g = 0.275, 95% CI = 0.10
to 0.45, p = .002). There was significant heterogeneity across the
study data (Q = 141.4, p < .01, I2 = 89.4%) and some indication
of publication bias (Egger's regression intercept = 1.67, p = .025;
see funnel plot in Supplemental Digital Content 3, http://links.lww.
com/PSYMED/A539). Nonetheless, the random-effects trim-and-fill
analysis found the estimated effect size to be larger and still statisti-
cally significant when accounting for publication bias (recalculated
at g = 0.408, 95%CI = 0.2 to 0.60, p < .01). Furthermore, significant
effects from dietary interventions on depression were also observed
in the sensitivity analysis including only the RCTs with high-quality
ratings from the ADA Quality Assessment (n = 11, n = 45,469, g =
0.321, 95% CI = 0.12 to 0.53, p = .002, Q = 131.1, I2 = 92.4%).
Prespecified Subgroup Analyses for Depression
Table 2 displays full results of all meta-analyses on depression out-
comes in primary and subgroup analyses. The pooled effect size
(g) on depressive symptoms across 10 dietary interventions that
compared with habitual diet alone (or “inactive” control conditions)
was 0.308 (n = 44,319, 95%CI = 0.02 to 0.6, p = .038), indicating a
FIGURE 1. Meta-analysis of the effects of dietary interventions on depressive symptoms. Box size represents study weighting. Diamond
represents overall effect size and 95% CIs.
TABLE 2. Effects of Dietary Interventions on Symptoms of Depression
Sample Meta-Analysis Heterogeneity
Studies Diet/Control, n/n Hedge's g 95% CI p Q p I2
Main analysis 16 18,746/27,080 0.275 0.100 0.450 .002 141.4 <.01 89.39
High-quality studies 11 18,567/26,902 0.321 0.116 0.526 .002 131.08 <.01 92.37
Diet versus active control 10 1027/921 0.174 0.012 0.335 .035 22.8 .007 60.56
Diet versus inactive control 10 18,022/26,297 0.308 0.017 0.599 .038 115.9 <.01 92.24
Nonclinical depression 15 18,715/27,055 0.246 0.070 0.423 .006 132.69 <.01 89.4
Diet + exercise versus exercise alone 2 139/137 0.265 0.030 0.500 .027 0.008 .928 0.000
Comparative subgroup analyses for depression outcomes
Aim: improving nutrition 9 560/610 0.365 −0.024 0.753 .066 71.9 <.01 88.9
Aim: reducing % fat intake 4 17,601/26,307 0.477 0.069 0.884 .022 53.1 <.01 94.35
Aim: inducing weight loss 4 585/483 0.212 0.087 0.338 .001 2.21 .529 0.00
Nutrition professional 12 18,618/26,890 0.329 0.124 0.535 .002 136.83 <.01 91.96
No nutrition professional 4 128/190 0.124 −0.124 0.371 .328 3.487 .322 13.961
>75% female sample 8 17,706/26,314 0.195 0.055 0.336 .007 18.97 .008 63.10
>75% male sample 4 366/362 −0.208 −0.449 0.033 .091 5.17 .160 41.93
100% female sample 6 17,739/26,141 0.164 0.019 0.310 .027 18.97 .008 63.10
100% male sample 3 353/352 −0.176 −0.427 0.074 .168 5.17 .16 41.93
CI = conflict of interest.
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small to moderate significant effect. Effects were slightly smaller
but still statistically significant, when compared with “active” control
conditions (n = 10, n = 1,948, g = 0.174, 95% CI = 0.01 to 0.34,
p < .001). Both waitlist- and active-controlled subgroups had high
heterogeneity among included studies, with no evidence of publi-
cation bias significantly altering the findings (Table 2).
For prespecified subgroup analyses on clinical versus nonclin-
ical populations, only one study used a clinically depressed sample
(n = 67), showing significantly greater reduction in depressive
symptoms from a 12-week modified Mediterranean diet interven-
tion in comparison with “social support” (17). Dietary interven-
tions reduced depressive symptoms significantly more than
control conditions among the remaining 15 trials in nonclinically
depressed individuals (n = 45,770, g = 0.246, 95% CI = 0.07 to
0.423, p = .006). In addition, preplanned subgroup analyses com-
paring “diet plus exercise” combination interventions to exercise
alone found a small positive effect on depressive symptoms from
the interventions that had the dietary component (g = 0.265,
95% CI = 0.03 to 0.50, p = .027) although this was based only
on two studies (n = 276).
Post hoc Analyses of Factors Influencing Dietary
Intervention Effects on Depression
Post hoc subgroup analyses were applied to explore, where possi-
ble, how interventional and participant characteristics may affect
study findings. Full results are shown in Table 2. Regarding the
design of dietary interventions, significant reductions in depres-
sion were observed from those primarily aiming to induce
bodyweight loss (n = 4, n = 1068, g = 0.212, 95% CI = 0.09 to
0.34, p = .001) and those aiming to reduce fat intake (n = 4, n =
43,638, g = 0.477, 95% CI = 0.07 to 0.89, p = .022). Similar sized
effects were observed from interventions primarily aiming to im-
prove nutritional intake (n = 9, n = 1170, g = 0.365, 95% CI =
−0.02 to 0.75), although this subgroup fell short of statistical sig-
nificance ( p = .066). Studies specifying the involvement of a
nutritional professional (e.g., dietitians or nutritionists) in the
delivery of dietary interventions observed a significant effect on
depressive symptoms (n = 12, n = 45,508, g = 0.329, 95% CI =
0.12 to 0.54, p = .002), whereas those that were delivered without
dietitian/nutritionist professional involvement had no greater ef-
fects than control conditions (n = 4, n = 318, g = 0.124, 95% CI =
−0.12 to 0.37, p = .328).
Finally, as shown in Figure 2, studies with mostly female sam-
ples (i.e., >75% female; eight studies) observed significant posi-
tive effects on depressive symptoms from dietary interventions
(g = 0.195, 95% CI = 0.06 to 0.37, p = .007), whereas those with
mostly male samples (>75% male, four studies) observed a slight
worsening of depressive symptoms from dietary interventions,
which approached statistical significance (g = −0.208, 95%
CI = −0.45 to 0.03 p = .091). This finding persistedwhen examining
only the studies with 100% female samples (six studies, g = 0.164,
95% CI = 0.02 to 0.31, p = .027) or 100% male samples (three
FIGURE 2. Meta-analysis showing differential effects of dietary interventions in male versus female samples, on (A) a symptoms of
depression and (B) symptoms of anxiety. Box size represents study weighting. Diamond represents overall effect size and 95% CIs.
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studies, g = −0.176, 95% CI = −0.43 to 0.07, p = .17), with sig-
nificantly greater effects from dietary interventions on depres-
sion observed in female sample studies (p = .021 between
subgroups). Exploratory meta-regression analyses examining in-
tervention length (weeks), study quality (ADA scale) and sample
age (mean average, years) found no relationships between these
variables and observed effects of diet on depression (full results
presented in Supplemental Digital Content 4, http://links.lww.
com/PSYMED/A540).
The Effects of Dietary Interventions on Anxiety
As shown in Figure 3, random-effects meta-analysis of 11 RCTs
reporting outcome data from 2270 individuals found no overall ef-
fect of dietary interventions on anxiety compared with control con-
ditions (g = 0.100, 95% CI = −0.036 to 0.235, p = .148, Q = 18.5,
I2 = 46.1). A sensitivity analysis including only studies with
high-quality ADA ratings also found no effect of dietary interven-
tions on anxiety (n = 8, n = 2005, g = 0.105, 95% CI = −0.06 to
0.27, p = .219,Q = 17.9, I2 = 60.92). Furthermore, there were no ef-
fects from dietary interventions on anxiety when compared with ei-
ther active control conditions (n = 6, n = 1,292, g = 0.046, 95%CI =
−0.13 to 0.22, p = .602) or habitual diet/inactive controls (n = 7, n =
984, g = 0.137, 95%CI = −0.08 to 0.36, p = .216), and no additional
effect of diet on anxiety were observed from studies comparing diet
and exercise combinations to exercise alone (n = 2, n = 175, g = 0.05,
95% CI = −0.19 to 0.29, p = .676). Full meta-analytic results are
displayed in Table 3. Moderate heterogeneity was present
across all of the analyses (I2 = 45.22%–48.2%), and there was
some indication of publication bias (Eggers regression intercept =
1.19, p = .093) although recalculating the results with trim-and-fill
analyses did not change the findings (i.e., no significant benefits
from dietary interventions for anxiety outcomes, all p > .05). No
FIGURE 3. Meta-analysis of the effects of dietary interventions on symptoms of anxiety. Box size represents study weighting. Diamond
represents overall effect size and 95% CIs.
TABLE 3. Effects of Dietary Interventions on Symptoms of Anxiety
Sample Meta-Analysis Heterogeneity
Studies Diet/Control, n/n Hedge's g 95% CI p Q p I2
Main analysis 11 1213/1057 0.100 −0.036 0.235 .148 18.5 .046 46.07
High-quality studies 8 1083/922 0.105 −0.062 0.271 .219 17.9 .012 60.92
Diet versus active control 6 690/602 0.046 −0.128 0.220 .602 9.653 .086 48.2
Diet versus inactive control 7 528/456 0.137 −0.080 0.355 .216 10.95 .090 45.22
Diet + exercise versus exercise alone 2 139/137 0.050 −0.185 0.285 .676 0.045 .833 0.000
Comparative subgroup analyses for anxiety outcomes
Aim: improving nutrition 6 440/429 0.397 −0.173 0.967 .173 61.8 <.01 91.9
Aim: reducing % fat intake 2 188/195 0.349 0.148 0.550 .001 0.401 .526 0.00
Aim: inducing weight loss 4 585/483 0.058 −0.067 0.183 .366 1.60 .659 0.00
Nutrition professional 9 1170/1065 0.273 0.020 0.526 .034 69.37 .000 87.0
No nutrition professional 2 43/42 0.248 −0.171 0.667 .247 0.123 .726 0.00
>75% female 6 493/472 0.211 0.085 0.337 .001 2.64 .755 0.000
>75% male 3 353/352 −0.190 −0.420 0.041 .107 3.43 .180 41.68
100% female 4 326/298 0.158 0.001 0.315 .048 1.41 .703 0.000
100% male 3 353/352 −0.190 −0.420 0.041 .107 3.43 .180 41.68
CI = confidence interval.
SYSTEMATIC REVIEW/META-ANALYSIS
Psychosomatic Medicine, V 81 • 265-280 276 April 2019
studies examined effects of dietary interventions in clinical anxiety
disorder samples.
Post hoc Analyses of Factors Influencing Dietary
Intervention Effects on Anxiety
No significant effects on anxiety were observed from the sub-
groups of dietary interventions that primarily aimed to improve
nutrition (n = 6, n = 869, g = 0.397, 95% CI = −0.17 to 0.97 p =
.174) or those aiming to reduce bodyweight (n = 4, n = 1068,
g = 0.058, 95%CI = −0.07 to 0.18, p = .366). A significant reduction
in anxiety was observed from those aiming to reducing fat intake
(g = 0.349, 95% CI = 0.15 to 0.55, p = .001), but the result must
be interpreted with caution given the small number of studies in
this subgroup (n = 2, n = 383). Studies specifying the involvement
of a nutritional professional in dietary interventions did observe a
significant, small positive effect on symptoms of anxiety (n = 9, n =
2235, g = 0.273, 95% CI = 0.0.02 to 0.53, p = .034), whereas those
who did not report dietitian/nutritionist involvement had no effects
(n = 2, n = 85, g = 0.242, 95% CI = −0.17 to 0.67, p = .247).
As with the depression outcomes, subgroups of studies using
mostly (>75%) female samples observed significant positive ef-
fects on anxiety from dietary interventions (n = 6, n = 965, g =
0.211, 95% CI = 0.09 to 0.34, p = .001), whereas those in mostly
male samples observed nonsignificant negative effects (g = −0.19,
95% CI = −0.42 to 0.04, p = .107). Inspection of both individual
and pooled study effects revealed that dietary interventions in
mostly/entirely female samples consistently had a positive direction
of effect on both symptoms of depression (Figure 2A) and anxiety
(Figure 2B). Conversely, effects of dietary interventions in the mostly
(or entirely) male samples were consistently negative for both depres-
sion and anxiety (Figure 2A) and anxiety ( Figure 2B).
DISCUSSION
To our knowledge, this is the first meta-analysis to examine the effi-
cacy of dietary interventions for depression and anxiety. Our system-
atic search identified 16 independent studies, reporting outcomes
of dietary intervention RCTs across 45,826 participants. The main
analysis found that dietary interventions had a small positive effect
on depressive symptoms (g = 0.275, 95% CI = 0.10 to 0.45),
which remained significant even after adjusting for study quality
and publication bias. However, only one of the 16 trials used a
sample with primary diagnosis of clinical depression (17), with
all the remaining 15 studies investigating effects of dietary inter-
ventions on symptoms of depression in nonclinical depression
samples. A further limitation to this is the publication bias found
in the primary analysis. However, the effects of dietary interven-
tions were still statistically significant after correcting for this. In
addition, our subgroup analyses found that positive effects of die-
tary interventions for depressive symptoms were observed in both
studies using inactive control conditions (g = 0.308, p = .038) and
active control conditions (g = 0.174, p = .035), indicating the ben-
eficial effects of dietary interventions on mood extend beyond just
general intervention effects.
A final limitation is the significant heterogeneity in the meta-
analyses, likely stemming from the broad inclusion criteria. Because
substantial heterogeneity was also present in the subgroup analyses,
this indicates that significant between-study differences in dietary ef-
fect sizes also existed when grouping by specific intervention types.
Thus, it was difficult to establish the most effective components
of dietary interventions for depression, because we found no
significant differences between dietary interventions primarily
aimed at (a) reducing bodyweight, (b) improving nutrition, or
(c) decreasing dietary fat intake. However, this is perhaps unsur-
prising, because although the primary aims of the interventions
did vary, the actual content of the all dietary intervention generally
hold some common features, such as aiming to reduce the intake
of “junk” foods (e.g., high-fat, high-sugar discretionary foods
and takeaways), while replacing these with high-fiber, nutrient-
dense alternatives, such as vegetables.
Implications and Recommendations for Future Research
The mechanisms through which these dietary changes can benefit
mental health have yet to be fully established. However, diet may
act via several pathways that are implicated in mental health.
These include pathways related to oxidative stress, inflammation,
and mitochondrial dysfunction, which are disrupted in people with
mental disorders (43). Gut microbiota dysbiosis has also been im-
plicated because of emerging research demonstrating involvement
of the microbiome in the modulation of stress response, immune
function, neurotransmission, and neurogenesis (44). A healthy diet
typically contains a wide variety of bioactive compounds that can
beneficially interact with these pathways. For example, vegetables
and fruits contain, in addition to beneficial vitamins, minerals and
fiber, a high concentration of various polyphenols that seem to be
associated with reduced rates of depression in limited observational
studies, potentially because of their anti-inflammatory, neuroprotec-
tive, and prebiotic properties (45,46). Furthermore, vitamins (e.g., B
vitamins), fatty acids (e.g., omega 3 fatty acids), minerals (e.g., zinc,
magnesium), and fiber (e.g., resistant starch) as well as other bioac-
tive components (e.g., probiotics), which are typically abundant in
healthy dietary patterns, may also be protective from mental illness
(44). Alongwith increasing the intake of beneficial nutrients, dietary
interventions may also impact on mental well-being by reducing the
consumption of unhealthy food associated with increased risk for
depression, such as processed meats, refined carbohydrates, and
other inflammatory foods (8,9). Unhealthy diets are also high in
other compounds that may negatively affect these pathways. For ex-
ample, elements commonly found in processed foods such as satu-
rated fatty acids, artificial sweeteners, and emulsifiers may alter the
gut microbiome, which may activate inflammatory pathways (47).
Our results showed that dietary interventions that primarily
targeted weight loss also significantly reduced symptoms of de-
pression. The psychological benefits of weight loss diets observed
in our meta-analysis could be linked with reductions in obesity, be-
cause there is robust evidence from epidemiological data that over-
weight status is consistently associated with an elevated risk of
depression (48,49). Indeed, all four of the weight loss interventions
included in our meta-analysis were conducted in overweight/obese
samples. Although only three of these trials examined the correla-
tions between mental health and weight loss, these consistently
found that individuals who lost most weight during the trial also
had the greatest improvements in measures of psychological
well-being (16,25,31). Previous trials of multicomponent weight
loss interventions (which were ineligible for our meta-analysis)
have also shown that reductions in depressive symptoms follow-
ing health behavior programs are significantly correlated with
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reductions in bodyweight (50). The leading hypothesis for why
obesity is associated with depression is through inflammation, be-
cause this is a core feature of depressive illness (51) and excessive
adipose tissue increases the production of proinflammatory cyto-
kines (52). Indeed, recent preclinical research has shed further light
on pathways through which obesogenic diets impacts on mental
health, demonstrating that dietary-induced obesity reduces insulin
signaling in the brain and increases neuroinflammation, resulting
in depressive-like behaviors in rodent models (53). This is sup-
ported by recent research in human adolescent samples, which
has demonstrated that the protective effects of healthy diet on de-
pression risk is conferred through reduced body mass index and
associated inflammation (10). However, it is important to note that
the significant effects of weight loss diets on symptoms of depres-
sion in this meta-analysis were all observed in nonclinical samples
(i.e., individuals with mostly subthreshold depression). In those
with clinical depression, the recent SMILES trial showed large
positive effects of a dietary intervention in MDD without altering
the weight of participants (17). Instead, the trial found that changes
in diet quality for the 12-week period correlated closely with
changes in depressive symptoms. This is in accordance with the
weight of evidence in the extensive observational literature show-
ing that the association between diet quality and major depression
exists even independently of body weight (7) and the emerging ev-
idence from preclinical studies indicating poor diet can also influ-
ence brain health and function in absence of obesity (54).
None of our prespecified analyses found notable effects from
dietary interventions on symptoms of anxiety. This could be due
to a “floor effect,” whereby the low levels of anxiety in the non-
clinical samples examined to date make it difficult to observe
any notable effects of dietary interventions. Indeed, in the single
trial to use a sample of individuals with diagnosed affective disor-
ders (although of major depression), the participants also had bor-
derline clinical levels of anxiety at baseline, and these symptoms
were significantly reduced by the dietary intervention (17). Future
RCTs are required to confirm or refute the effects of dietary inter-
ventions on those with clinically diagnosed anxiety disorders.
Clinical Implications
A key issue in clinical applicability of our findings is the lack of
studies in clinically depressed samples meaning that most evi-
dence of dietary interventions reducing depressive symptoms only
applies to nonclinical depression to date. Although the SMILES
trial was the first to examine the efficacy of dietary interventions
in a clinically depressed sample, another more recent RCT (the
HELFIMED trial) has also indicated the efficacy of a Mediterra-
nean diet for treating depression (55). However, this study was in-
eligible for our meta-analysis because of the intervention also
including fish oil supplements (an active treatment for depression)
(56), thus making it impossible to determine whether reductions in
depression were due to dietary changes or fish oil treatment. Fur-
thermore, a recent economic evaluation of the SMILES trial pro-
vides support for the cost-effectiveness of such an approach to
treating depression, with participants in the dietary support condi-
tion generating substantially reduced societal and health sector
costs compared with the social support condition (57). However,
it is important to consider that, to date, no trials have yet compared
the efficacy of dietary interventions to antidepressant medications.
Thus, dietary intervention can only be considered an adjunctive
strategy for managing depressive symptoms at this point.
Nonetheless, the significant benefits observed for subclinical/
secondary depression are also of considerable value. The benign
nature of dietary interventions, along with the established benefits
of diet for physical health, suggests that dietary improvement
could be an ideal option for low-intensity treatment or for individ-
uals to adopt themselves as a self-management approach for reduc-
ing subclinical depressive symptoms. Furthermore, diet seems to
improve depression even when used alongside other more estab-
lished self-management strategies, such as physical activity (50),
because pooled data from studies examining “diet plus exercise”
combinations showed significant additional benefits compared
with exercise alone. However, this result should be interpreted
with caution because of the low number of studies included in
the subgroup analysis (n = 2, n = 276). Our subgroup analyses also
indicated that interventions delivered by registered dietitians and
professional nutritionists have significant benefits for both depres-
sion and anxiety, whereas those delivered by other individuals
(e.g., research staff ) did not. Although preliminary, the finding
from this subgroup analysis is in line with a previous research
showing that interventions that use dietitians have significantly
better effects on weight management in severe mental illness com-
pared with those who use other types of health professionals (58,59).
Our meta-analysis also found that studies using primarily fe-
male samples observed significant mental health benefits from di-
etary interventions (for depression and anxiety), whereas those
with male samples did not, even indicating a trend toward a nega-
tive effect (Figure 2). Again, because these subgroup analyses
consisted of only few studies for each sex (n = 8 studies in females,
n = 4 studies in males), definitive conclusions cannot be drawn
from these data. However, these findings could be potentially be
explained by three sex-specific factors. First, because females have
a higher presence of mood disorders across the population, this
may create greater scope for a significant benefit from dietary in-
terventions (60). Second, differences in dietary effects on mood
could be linked to sex differences in metabolism and body compo-
sition, whereby women may be more responsive to diets that alter
glucose or fat metabolism (61). Third, sociocultural sex differ-
ences in expectations surrounding diet and health beliefs may in-
fluence outcomes of dietary interventions. For example, men rate
certain health behaviors, including diet, as less important than
women, have lower nutrition knowledge, and women seek nutri-
tion counseling more frequently than men (62,63). Thus, women
may be more likely thanmales to adopt health behaviors as recom-
mended. Future research should examine the extent to which sex
differences in adherence to dietary interventions explain the differ-
ential effects between sexes.
Beyond sex differences, future research should also aim to de-
termine the influence of several other confounding factors, which
have so far been overlooked. One key factor for future research to
examine is the interaction between dietary interventions with psy-
chotropic medications. Because depressive symptoms were used
as secondary outcomes in most studies here and conducted in non-
clinical samples, few studies have examined this to date. However,
preliminary insights on this issue can be gained by comparing tri-
als, which excluded individuals taking antidepressants, with those
studies that included high proportions of antidepressant users.
For instance, the single trial of an MDD sample (in which >75%
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of the intervention group were taking antidepressants) observed
large, significant benefits of dietary intervention compared with
the counseling control group (17), whereas the two trials that spe-
cifically excluded individuals taking antidepressants from their
analyses observed no significant differences between dietary inter-
ventions and problem-solving therapy for symptoms of depression
(27,28). Other important confounding factors to be examined in
future research include medical comorbidities (particularly cardio-
metabolic complications) and substance abuse, both of which could
modify the impact of dietary interventions on mental well-being.
SUMMARYAND CONCLUSIONS
The consistently significant and positive effects of dietary interven-
tions on depressive symptoms observed across all random-effects
meta-analyses, even in high-quality studies, strongly suggests that
diet can play a role in the treatment and also self-management of
depressive symptoms across the population. Because pooled effect
sizes were mostly classified as “small,” further research is war-
ranted to distil both the key components and mechanistic actions
of diet for mental health to develop more refined, targeted, and
thus perhaps more effective interventions. In addition, given the
potentially cumulative effects of diet and exercise together, future
research should explore the modification of diet in concert with
multiple other life-style modifications to provide a more integrated
approach (64). Finally, further research should also be directed to-
ward determining cost-effective and sustainable methods for pro-
viding dietary interventions within mental healthcare services,
along with developing and evaluating public health schemes for
dietary improvement across the population.
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